Kestra Private Wealth Services LLC raised its stake in Danaher Corporation (NYSE:DHR – Free Report) by 33.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,654 shares of the conglomerate’s stock after purchasing an additional 5,233 shares during the period. Kestra Private Wealth Services LLC’s holdings in Danaher were worth $4,728,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. JPL Wealth Management LLC purchased a new position in Danaher in the third quarter valued at about $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at about $26,000. WFA of San Diego LLC purchased a new position in Danaher in the second quarter valued at about $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher in the third quarter valued at about $27,000. Finally, TruNorth Capital Management LLC purchased a new position in Danaher in the third quarter valued at about $28,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Trading Down 0.8%
Shares of DHR stock opened at $179.23 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The company has a market cap of $126.85 billion, a price-to-earnings ratio of 34.67, a PEG ratio of 2.41 and a beta of 0.95. The stock has a 50 day simple moving average of $194.58 and a 200-day simple moving average of $213.63. Danaher Corporation has a 1-year low of $175.00 and a 1-year high of $242.80.
Danaher Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, April 24th. Stockholders of record on Friday, March 27th were issued a dividend of $0.40 per share. The ex-dividend date was Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
Analysts Set New Price Targets
Several equities analysts have issued reports on the company. Robert W. Baird cut their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. Rothschild & Co Redburn set a $205.00 price target on Danaher in a report on Friday, April 17th. Evercore raised their price target on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. Finally, Morgan Stanley lowered their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Eighteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $240.70.
Get Our Latest Analysis on DHR
Insider Buying and Selling at Danaher
In related news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president directly owned 5,099 shares in the company, valued at $1,060,642.99. This trade represents a 20.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 10.80% of the company’s stock.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
